Patrick Hsu

Patrick D. Hsu (born June 25, 1993) is an American bioengineer, entrepreneur, and investor specializing in CRISPR, machine learning, synthetic biology, and gene therapy. He is an assistant professor of bioengineering at the University of California, Berkeley and a co-founder of Arc Institute, a research organization focused on accelerating biomedical discovery. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Patrick D Hsu', query time: 0.02s Refine Results
  1. 1
    Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells

    Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells by Josh Tycko, Luis A. Barrera, Nicholas C. Huston, Ari E. Friedland, Xuebing Wu, Jonathan S. Gootenberg, Omar O. Abudayyeh, Vic E. Myer, Christopher J. Wilson, Patrick D. Hsu

    Published 2018-07-01
    Get full text
    Article
  2. 2
    Publisher Correction: Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells

    Publisher Correction: Pairwise library screen systematically interrogates Staphylococcus aureus Cas9 specificity in human cells by Josh Tycko, Luis A. Barrera, Nicholas C. Huston, Ari E. Friedland, Xuebing Wu, Jonathan S. Gootenberg, Omar O. Abudayyeh, Vic E. Myer, Christopher J. Wilson, Patrick D. Hsu

    Published 2018-08-01
    Get full text
    Article
  3. 3
    The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression.

    The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression. by Jin Wei, Mia Madel Alfajaro, Wesley L Cai, Vincent R Graziano, Madison S Strine, Renata B Filler, Scott B Biering, Sylvia A Sarnik, Sonam Patel, Bridget L Menasche, Susan R Compton, Silvana Konermann, Patrick D Hsu, Robert C Orchard, Qin Yan, Craig B Wilen

    Published 2023-07-01
    Get full text
    Article
  4. 4
    DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner.

    DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner. by Madison S Strine, Wesley L Cai, Jin Wei, Mia Madel Alfajaro, Renata B Filler, Scott B Biering, Sylvia Sarnik, Ryan D Chow, Ajinkya Patil, Kasey S Cervantes, Clayton K Collings, Peter C DeWeirdt, Ruth E Hanna, Kevin Schofield, Christopher Hulme, Silvana Konermann, John G Doench, Patrick D Hsu, Cigall Kadoch, Qin Yan, Craig B Wilen

    Published 2023-06-01
    Get full text
    Article
  5. 5
    Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

    Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade by Crismita Dmello, Junfei Zhao, Li Chen, Andrew Gould, Brandyn Castro, Victor A. Arrieta, Daniel Y. Zhang, Kwang-Soo Kim, Deepak Kanojia, Peng Zhang, Jason Miska, Ragini Yeeravalli, Karl Habashy, Ruth Saganty, Seong Jae Kang, Jawad Fares, Connor Liu, Gavin Dunn, Elizabeth Bartom, Matthew J. Schipma, Patrick D. Hsu, Mahmoud S. Alghamri, Maciej S. Lesniak, Amy B. Heimberger, Raul Rabadan, Catalina Lee-Chang, Adam M. Sonabend

    Published 2023-03-01
    Get full text
    Article

Search Tools: